Sirona Biochem CEO Quarterly Update Q2 2021
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona“) is pleased to provide the following update to shareholders.
Dear shareholders,
We are providing this update along with our quarterly results. We will continue to provide an update each quarter and will update our milestone list at that time as well.
It is important to appreciate that each of our projects relies on partners. Whether this is the manufacturing and supply organizations, the contract research groups that run our studies, or the potential commercial partners completing their own studies and reviews as part of due diligence. Our prospective global partners conduct due diligence that is extremely detailed and often takes longer than anticipated. Each of these partners has their own unique organizational structures and schedules and they are often met with challenges that cause delays. In the best of times this is the case, but in the past year we have dealt with far more. Sirona has internally managed recent global challenges with little to no adversity, but larger organization have been less successful.
We take this opportunity to apologize to our investment community for our mistakes when it came to estimating some of our project timelines and we will strive to do better going forward. We assure you that our projects have not been discontinued, that our science team is actively working on contributions to partner due diligence activities as well as expanding our pipeline with new IP, and that our business teams are continuously meeting with large global corporations to discuss ongoing and new partnerships.
The individual project updates are as follows:
TFC-1067
North America
We are very pleased that TFC-1067, our active ingredient for dark spots on or hyperpigmentation of the skin, has now been commercialized.
On March 10, 2021, we announced that Rodan + Fields (R+F) had successfully launched TFC-1067 as the active ingredient in the new REVERSE Targeted Dark Spot Corrector. We are extremely proud to have contributed to the first commercialization of the technology developed by our award-winning CSO Dr. Geraldine Deliencourt-Godefroy. This launch not only validated our technology but has also opened the door for further collaborations as global players have increased confidence to add TFC-1067 to their product portfolios.
Commercial products that include TFC-1067 will have different levels of efficacy depending on the concentration of our active and the formula (cream, serum, etc) developed by the commercial partner. In addition, all spot correctors take time to be effective and the visible results steadily become more apparent over time. Even the industry standard, hydroquinone, takes weeks to show an effect despite achieving results partially through toxicity. TFC-1067 blocks the formation of new pigment and existing pigment must degrade over time. Our science team is convinced we developed an excellent formulation in our clinical trials and remain highly confident in our product. Participants in our second double blind clinical trial support this conclusion. This trial demonstrated, successfully, the powerful effect of our TFC-1067 formulas with 100% of participants seeing an improved complexion and concluding they would buy this product.
With great results confirmed by consumers, we have again increased manufacturing in China and have currently arranged to secure an inventory of product that will be able to meet the growing demand. Our manufacturing partner, WuXi AppTec has provided dedicated resources for our compound and can produce significant quantities with little turnaround time. As we continue to scale, product supply will not be an issue.
Our second clinical trial for TFC-1067 completed in Feb 2021. At this time, our pharmaceutical partner continues their due diligence and will do so for a previously agreed upon time. A successful transaction with the trial partner is management’s goal as it would be transformational for Sirona. While many global pharmaceutical and dermatological companies continue to approach Sirona with interest in TFC-1067, we are obligated to delay in-depth discussions involving the clinical trial results until our partner has completed analysis of the clinical results and determined their next steps. Due diligence by global leaders takes time no matter how confident they are in the ultimate commercial success since they follow meticulous procedures with large teams. We observed this with Rodan + Fields as great care is required to maintain the brand excellence.
Our VP of Operations, Michelle Seltenrich, attended BIO from June 14th to June 18th and met with 12 organizations from the following countries/regions: Japan, Korea, China, USA, Canada, Europe to discuss various programs. Each of these meetings was pursued by the larger organization and will be followed up with data exchange.
We will be successful in further commercialization of TFC-1067 globally.
Asia
We continue to implement our Asia strategy and are in discussions with a China-based company which has established cosmetic development excellence as discussed in our last news update. An evolving and varied regulatory landscape for new compounds throughout Asia has created challenges. Each country in Asia has enormous commercial potential and we do not want to miss any of these opportunities. As such, we are advancing another compound, TFC-1394, from our patented library of skin lighteners to the same level as TFC-1067. This will occur over the next 12-18 months and ensure that country regulatory testing, if required, can be performed by other companies. We will then be able to launch in every country where a market exists in this $20 Billion USD industry. Our scientists have outlined a development path based on the expertise we have developed which is both efficient and affordable. It will occur in parallel to commercialization of TFC-1067 and not delay current plans. The value of our portfolio, which includes TFC-1067 and TFC-1394, will grow as they advance towards becoming a new industry gold standard as both safe and effective compounds. Having a regional partner is an important component in successful achieving our goals in a timely manner.
Tinyi Trading Company remains on board to be a distribution partner, however, with current discussions ongoing, we wait to see if the new partner in China seeks exclusive distribution. Ultimately, we will decide in the best interests of our company and shareholders.
TFC-039
Human Diabetes
Our partner, Wanbang Biopharmaceuticals, has informed us that our compound for type 2 diabetes (TFC-039) has completed their Phase I studies and the data is in the analysis phase. We expected to hear the results of this before the Chinese New Year in early February, however, they have experienced delays in the data analysis. We are now waiting and pushing to have a final report of these results and will update shareholders as soon as material information is available for release.
Animal Health
TFC-039 for animal health continues to progress. We are now in contact with four international companies on this project. Two additional global animal health companies reached out to our team, and we have exchanged data that they are currently reviewing.
We are evaluating the best way forward and still anticipate having both a manufacturing and a commercialization partner for the animal health product. We have established assistance from Wanbang in this regard and have their full commitment.
Other Indications
The team at TFChem is investigating further indications for TFC-039 and have identified the target diseases. Once the patents have been established, we will provide more information. Premature release of information can prevent the ability to patent a technology and our company relies on IP as assets, so we ask for patience in this regard.
Anti-Aging
Our anti-aging library has been completed and a lead compound has been chosen. These actives target multiple pathways in the aging process in different layers of the skin, which creates a very innovative treatment against skin aging and wrinkles. However, the complexity of this means that the compound will require multiple and extensive evaluations with different contract research organizations to identify a mechanism of action. We are now planning and executing the studies required for clinical testing. Several studies in this regard, including safety studies have started and we will announce initial results by Q4 of the calendar year. New indications for these compounds have been discovered through the evaluation process and has expanded the potential target commercial opportunities and will lead to another specific patent in 2022.
In our last update, we stated that the project was introduced to several companies at BIO JPM. The team in France put together a very detailed information package for this project, which contains the preclinical studies and results. This was distributed to several companies at the end of May and again following BIO in June. Discussions with partners remain preliminary at this stage.
Antiviral
Our antiviral compounds are in the chemistry phase, and we will update as progress is made. Several actives have been already prepared and we are building our portfolio for evaluation in different assays. There remains a critical unmet need for drugs that can halt the extreme progression of some viruses. We have identified compound structures that fit our platform and have a clear path of development.
Financing
Sirona’s last private placement financing was 2 years ago, a similar financing is not planned. Management has a strategy on how to move forward including non-dilutive sources currently being explored.
Despite our limited recent news flow, we are very excited with our progress towards future partnerships and licencing deals. Commercialization of the pipeline is becoming a growing reality which will ultimately reward our shareholders.
Dr. Howard Verrico, CEO
About Sirona Biochem Corp.
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in News Home, Sirona Biochem
Canada Silver Cobalt Begins Testwork Using Re-2Ox on Granada Gold Mine Rubidium Mineralized Material for the Storage Battery Market
Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (“Canada Silver Cobalt”) and Granada Gold Mines Inc. (“Granada” or “Granada Gold”) (TSXV: GGM) (OTC: GBBFF) (Frankfurt: B6D) are pleased to jointly announce that Canada Silver Cobalt has begun preliminary test work at SGS, Lakefield, Canada on mineralized material from the Granada Gold Mine in Rouyn-Noranda, Quebec.
The planned test work was announced earlier this year (March 30, 2021 joint news release) after Granada Gold announced the unexpected discovery of a rare earth and alkali metals deposit at the Granada property in Quebec during exploration for gold.
Rubidium, one of the discovered alkali metals, showed particularly high assays and potential value based on quoted market prices (March 23 and May 12, 2021 Granada news releases) and therefore is an important part of the focus of the Re-2Ox test work.
Rubidium has numerous applications in various industries (see below), including in sodium-ion batteries which may see significant growth ahead due to their reported cost-effectiveness as stationary energy storage for homes, the grid and data centres.
Frank J. Basa, P.Eng., CEO, commented: “Granada currently expects that rubidium will be treated as a zero-cost, by-product alkali metal recovery from Granada’s gold mineralized resource. The preliminary test program will evaluate the potential recovery of rubidium mineralization and the subsequent amenability of the Re-2Ox process for the leaching and production of rubidium salts. Granada Gold intends to review the viability of suppling rubidium salts as a by-product of gold processing for evaluation into the new fast-evolving sodium-ion storage battery market.”
Planned Re-2Ox testing
A 10-kilogram drill core sample was sent to SGS, Lakefield for mineralogical studies to identify the minerals associated with rubidium. The studies indicated so far that rubidium is likely in the micas and/or K-feldspars. Analytical results returned a grade of 1,238.5 ppm for rubidium. Distinct rubidium minerals do not commonly occur in nature and are almost always associated with feldspars and micas.
The test program at SGS will be undertaken in two stages. The first stage will consist of straight forward flotation followed by leaching using the Re-2Ox process. The second stage is straight leaching using the Re-2Ox process. The test program was developed to target rubidium in the mineralized zones.
Rubidium at Granada
The Rubidium mineralized material at Granada has been found to be on top on the gold-bearing mineralized material that the company is targeting as a gold mineral resource and for mining. Drill hole GR-20-22 was drilled to a depth of 1,626 meters on the Big Claim 1.6 kilometers west on strike from the discovery drill hole GR-20-20 which was drilled to depth of 588 meters. Drill hole GR-20-22 intercepted 21 distinct mineralized zones ranging in core length from 177 meters to 2.8 meters. Rare earths and alkali metals of note identified to date are caesium (Cs), rubidium (Rb), scandium (Sc), zirconium (Zr), cerium (Ce), gallium (Ga), hafnium (Hf), neodymium (Nd) and strontium (Sr) — others pending. While still to be determined, the company may be in the position of mining the rare earth and alkali mineralized zones to access the gold-bearing mineralized material. The entire size of the rare earth and alkali metals deposit has not yet been determined.
Rubidium in Sodium-Ion Batteries
Rubidium salts have been commonly used as an electrolyte to improve the efficiency cycle of sodium-ion batteries. In recent years, it has been implemented into a larger scale for further technological advances to improve the performance rate and better cyclability in the batteries. Sodium-ion batteries have demonstrated about half the energy density of lithium-ion batteries and have applications as stationary storage like renewable energy for homes and the grid or backup power for data centers, where cost is more important than size and energy density. Currently available information places the cost of sodium-ion batteries to be about 10–20 percent less than lithium-ion batteries.
Sodium-ion batteries use abundant, cheap, and benign materials. In the Earth’s crust there is over one-thousand times more sodium than lithium. It also costs less to extract and purify. Sodium metal oxide cathodes are typically used in batteries and the anodes are carbon just like lithium-ion batteries but can be made from plentiful metals such as iron and manganese. The Department of Energy’s Advanced Research Projects Agency–Energy in September 2020 awarded Santa Clara, California-based Natron Energy $19.9 million US dollars as part of a new program to fast-track technologies, with the goal of advancing their commercialization efforts. The batteries are now in low-volume commercial production. Natron’s first customers are data centers and telecom companies. Sodium-ion batteries are also more stable and safer than lithium-ion. They have a wider temperature range, are nonflammable, and do not have thermal runaway.
Additional Applications of Rubidium in Industry
Applications for rubidium and its compounds include biomedical research, electronics, specialty glass, and pyrotechnics. Specialty glasses are the leading market for rubidium; rubidium carbonate is used to reduce electrical conductivity, which improves stability and durability in fiber optic telecommunications networks. Biomedical applications include rubidium salts used in antishock agents and the treatment of epilepsy and thyroid disorder; rubidium-82, a radioactive isotope used as a blood-flow tracer in positron emission tomographic imaging; and rubidium chloride, used as an antidepressant. Rubidium atoms are used in academic research, including the development of quantum-mechanics-based computing devices, a future application with potential for relatively high consumption of rubidium. Quantum computing research uses ultracold rubidium atoms in a variety of applications. Quantum computers, which have the ability to perform more complex computational tasks than traditional computers by calculating in two quantum states simultaneously, were expected to be in prototype phase by 2025. Rubidium’s photo-emissive properties make it useful for electrical-signal generators in motion-sensor devices, night vision devices, photoelectric cells (solar panels), and photomultiplier tubes. Rubidium is used as an atomic resonance-frequency-reference oscillator for telecommunications network synchronization, playing a vital role in global positioning systems. Rubidium-rich feldspars are used in ceramic applications for spark plugs and electrical insulators because of their high dielectric constant. Rubidium hydroxide is used in fireworks to oxidize mixtures of other elements and produce violet hues (Source USGS).
Qualified Person
The technical information in this news release was prepared under the supervision of Mr. Frank J. Basa, P.Eng., CEO of Canada Silver Cobalt Works Inc., a qualified person in accordance with National Instrument 43-101.
About Canada Silver Cobalt Works Inc.
The Castle Property is 15 km east of Aris Gold Corp’s Juby gold deposit, 30 km due south of Alamos Gold’s Young-Davidson mine, 75 km southwest of Kirkland Lake Gold’s Macassa Complex, and 100 km southeast of new gold discoveries in the Timmins West area.
Canada Silver Cobalt Works released the first-ever resource in the Gowganda Camp and greater Cobalt Camp in May 2020. A total of 7.56 million ounces of silver in Inferred resources comprising very high-grade silver (8,582 grams per tonne un-cut or 250.2 oz/ton) in 27,400 tonnes of material from two sections (1A and 1B) of the Robinson Zone beginning at a vertical depth of approximately 400 meters were identified. The discovery remains open in all directions (mineral resources that are not mineral reserves do not have demonstrated economic viability) (refer to Canada Silver Cobalt Works Press Release May 28, 2020) Report reference: Rachidi, M. 2020, NI 43-101 Technical Report Mineral Resource Estimate for Castle East, Robinson Zone, Ontario, Canada, with an effective date of May 28, 2020, and a signature date of July 13, 2020).
Canada Silver Cobalt’s flagship Castle mine and 78 sq. km Castle Property features strong exploration upside for silver, cobalt, nickel, gold and copper in the prolific past producing Gowganda high-grade Silver District of Northern Ontario. With underground access at Castle, a pilot plant to produce cobalt-rich gravity concentrates on site, a processing facility (TTL Laboratories) in the town of Cobalt, and a proprietary hydrometallurgical process known as Re-2Ox for the creation of technical grade cobalt sulphate as well as nickel-manganese-cobalt (NMC) formulations, Canada Silver Cobalt is strategically positioned to become a Canadian leader in the silver-cobalt space. More information at www.canadasilvercobaltworks.com
“Frank J. Basa”
Frank J. Basa, P. Eng.
Chief Executive Officer
- Published in Canada Cobalt Works, Mining, News Home
Granada Gold Mine Announces that Canada Silver Cobalt Begins Testwork Using Re-2Ox on Granada’s Rubidium Mineralized Material for the Storage Battery Market
Granada Gold Mines Inc. (TSXV: GGM) (OTC: GBBFF) (Frankfurt: B6D) (“Granada” or “Granada Gold”) and Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (“Canada Silver Cobalt”) are pleased to jointly announce that Canada Silver Cobalt has begun preliminary test work at SGS, Lakefield, Canada on mineralized material from the Granada Gold Mine in Rouyn-Noranda, Quebec.
The planned test work was announced earlier this year (March 30, 2021 joint news release) after Granada Gold announced the unexpected discovery of a rare earth and alkali metals deposit at the Granada property in Quebec during exploration for gold.
Rubidium, one of the discovered alkali metals, showed particularly high assays and potential value based on quoted market prices (March 23 and May 12, 2021 Granada news releases) and therefore is an important part of the focus of the Re-2Ox test work.
Rubidium has numerous applications in various industries (see below), including in sodium-ion batteries which may see significant growth ahead due to their reported cost-effectiveness as stationary energy storage for homes, the grid and data centres.
Frank J. Basa, P.Eng., CEO, commented: “Granada currently expects that rubidium will be treated as a zero-cost, by-product alkali metal recovery from Granada’s gold mineralized resource. The preliminary test program will evaluate the potential recovery of rubidium mineralization and the subsequent amenability of the Re-2Ox process for the leaching and production of rubidium salts. Granada Gold intends to review the viability of suppling rubidium salts as a by-product of gold processing for evaluation into the new fast-evolving sodium-ion storage battery market.”
Planned Re-2Ox testing
A 10-kilogram drill core sample was sent to SGS, Lakefield for mineralogical studies to identify the minerals associated with rubidium. The studies indicated so far that rubidium is likely in the micas and/or K-feldspars. Analytical results returned a grade of 1,238.5 ppm for rubidium. Distinct rubidium minerals do not commonly occur in nature and are almost always associated with feldspars and micas.
The test program at SGS will be undertaken in two stages. The first stage will consist of straight forward flotation followed by leaching using the Re-2Ox process. The second stage is straight leaching using the Re-2Ox process. The test program was developed to target rubidium in the mineralized zones.
Rubidium at Granada
The Rubidium mineralized material at Granada has been found to be on top on the gold-bearing mineralized material that the company is targeting as a gold mineral resource and for mining. Drill hole GR-20-22 was drilled to a depth of 1,626 meters on the Big Claim 1.6 kilometers west on strike from the discovery drill hole GR-20-20 which was drilled to depth of 588 meters. Drill hole GR-20-22 intercepted 21 distinct mineralized zones ranging in core length from 177 meters to 2.8 meters. Rare earths and alkali metals of note identified to date are caesium (Cs), rubidium (Rb), scandium (Sc), zirconium (Zr), cerium (Ce), gallium (Ga), hafnium (Hf), neodymium (Nd) and strontium (Sr) — others pending. While still to be determined, the company may be in the position of mining the rare earth and alkali mineralized zones to access the gold-bearing mineralized material. The entire size of the rare earth and alkali metals deposit has not yet been determined.
Rubidium in Sodium-Ion Batteries
Rubidium salts have been commonly used as an electrolyte to improve the efficiency cycle of sodium-ion batteries. In recent years, it has been implemented into a larger scale for further technological advances to improve the performance rate and better cyclability in the batteries. Sodium-ion batteries have demonstrated about half the energy density of lithium-ion batteries and have applications as stationary storage like renewable energy for homes and the grid or backup power for data centers, where cost is more important than size and energy density. Currently available information places the cost of sodium-ion batteries to be about 10–20 percent less than lithium-ion batteries.
Sodium-ion batteries use abundant, cheap, and benign materials. In the Earth’s crust there is over one-thousand times more sodium than lithium. It also costs less to extract and purify. Sodium metal oxide cathodes are typically used in batteries and the anodes are carbon just like lithium-ion batteries but can be made from plentiful metals such as iron and manganese. The Department of Energy’s Advanced Research Projects Agency–Energy in September 2020 awarded Santa Clara, California-based Natron Energy $19.9 million US dollars as part of a new program to fast-track technologies, with the goal of advancing their commercialization efforts. The batteries are now in low-volume commercial production. Natron’s first customers are data centers and telecom companies. Sodium-ion batteries are also more stable and safer than lithium-ion. They have a wider temperature range, are nonflammable, and do not have thermal runaway.
Additional Applications of Rubidium in Industry
Applications for rubidium and its compounds include biomedical research, electronics, specialty glass, and pyrotechnics. Specialty glasses are the leading market for rubidium; rubidium carbonate is used to reduce electrical conductivity, which improves stability and durability in fiber optic telecommunications networks. Biomedical applications include rubidium salts used in antishock agents and the treatment of epilepsy and thyroid disorder; rubidium-82, a radioactive isotope used as a blood-flow tracer in positron emission tomographic imaging; and rubidium chloride, used as an antidepressant. Rubidium atoms are used in academic research, including the development of quantum-mechanics-based computing devices, a future application with potential for relatively high consumption of rubidium. Quantum computing research uses ultracold rubidium atoms in a variety of applications. Quantum computers, which have the ability to perform more complex computational tasks than traditional computers by calculating in two quantum states simultaneously, were expected to be in prototype phase by 2025. Rubidium’s photo-emissive properties make it useful for electrical-signal generators in motion-sensor devices, night vision devices, photoelectric cells (solar panels), and photomultiplier tubes. Rubidium is used as an atomic resonance-frequency-reference oscillator for telecommunications network synchronization, playing a vital role in global positioning systems. Rubidium-rich feldspars are used in ceramic applications for spark plugs and electrical insulators because of their high dielectric constant. Rubidium hydroxide is used in fireworks to oxidize mixtures of other elements and produce violet hues. (Source: USGS).
Qualified Person
The technical information in this news release was prepared under the supervision of Mr. Frank J. Basa, P.Eng., CEO of Granada Gold Mine Inc., a qualified person in accordance with National Instrument 43-101.
About Granada Gold Mine Inc.
Granada Gold Mine Inc. continues to develop the Granada Gold Property near Rouyn-Noranda, Quebec. Approximately 140,000 meters of drilling has been completed to date on the property, focused mainly on the extended LONG Bars zone which trends 2 kilometers east-west over a potential 5.5 kilometers of mineralized structure. The highly prolific Cadillac Break, the source of more than 75 million plus ounces of gold production in the past century, cuts through the north part of the Granada property, but is not necessarily indicative of mineralization hosted on the company’s property.
The Granada Shear Zone and the South Shear Zone contain, based on historical detailed mapping as well as from current and historical drilling, up to twenty-two mineralized structures trending east-west over five and a half kilometers. Three of these structures were mined historically from four shafts and three open pits. Historical underground grades were 8 to 10 grams per tonne gold from two shafts down to 236 m and 498 m with open pit grades from 3.5 to 5 grams per tonne gold.
Updated Mineral Resource
The updated resource at the Company’s Granada Gold project in Rouyn-Noranda, Quebec was estimated by SGS Canada and outlined in a January 29, 2021 news release. The final report was filed March 15, 2021 with an Effective date of December 15, 2020. The 43-101 Technical Report is titled: Granada Gold Project Mineral Resource Estimate Update, Rouyn-Noranda, Quebec, Canada authored by Yann Camus, P.Eng. and Maxime Dupéré, B.Sc, géo. Both of SGS Canada Inc.
Updated Mineral Resource Estimate Base Case with Details Between the Open Pit Portion and the Underground Portion
Type | Category | Tonnes | Au (g/t) | Gold Ounces |
In Pit | Measured1 | 3,756,000 | 1.89 | 228,000 |
Indicated | 1,357,000 | 2.55 | 111,000 | |
Measured+Indicated | 5,113,000 | 2.06 | 339,000 | |
Inferred | 34,000 | 11.29 | 12,000 | |
Underground | Measured | 37,000 | 4.22 | 5,000 |
Indicated | 807,000 | 4.02 | 104,000 | |
Measured+Indicated | 844,000 | 4.03 | 109,000 | |
Inferred | 1,244,000 | 6.33 | 253,000 |
1. | Cut-off grades are based on a gold price of US$1,600 per ounce, a foreign exchange rate of US$0.76 for CA$1, a gold recovery of 93% |
2. | Pit constrained mineral resources are reported at a cut-off grade of 0.9 g/t Au within a conceptual pit shell |
3. | Underground mineral resources are reported at a cut-off grade of 3.0 g/t Au within reasonably mineable volumes |
The Company is in possession of all mining permits required to commence the initial mining phase, known as the “Rolling Start”, which allows the company to mine up to 550 tonnes per day. Additional information is available at www.granadagoldmine.com.
“Frank J. Basa”
Frank J. Basa P. Eng.
President and Chief Executive Officer
- Published in Granada Gold Mine, Mining, News Home
Newlox Gold Appoints Prof. Giorgio de Tomi to Lead Brazil Initiative
Click Image To View Full Size
Vancouver, BC – TheNewswire – 24 June 2021 – Newlox Gold Ventures Corp. (“Newlox” or the “Company”) (CSE: LUX ) ( Frankfurt/Stuttgart: NGO ) | PINK (OTC : NWLXF ) (CNSX:LUX.CN) welcomes Professor Giorgio de Tomi, Ph.D., CEng, FIMMM to the Newlox Gold team. Professor de Tomi will head up Newlox’s Brazilian division to undertake market research and development, including the assessment of projects for Newlox Gold.
Newlox announced on June 16 th , 2021 , that the Company had entered the Brazilian market to develop future ESG-focused precious metals projects in partnership with local artisanal mining groups. This continues Newlox Gold’s growth through an ESG-centered partner mining model to provide environmental and social benefits to all stakeholders while supporting economic development in traditional artisanal mining communities.
Dr. de Tomi has over 30 years of experience in the resource sector and has a degree in mining engineering from the University of Sao Paulo, a Ph.D. from the Imperial College, London, and an MSc from Southern Illinois University, USA. He leads the Centre for Responsible Mining, at the University of São Paulo (USP) in Brazil, as an associate professor and former Head of the Department of Mining and Petroleum Engineering .
Dr. De Tomi is a Fellow of The Institute of Materials, Minerals & Mining (FIMMM, UK), Chartered Engineer CEng (Engineering Council, UK). He is a member of SME (USA) and acts as mining QP and CP for numerous mining enterprises worldwide. Currently, he is a member of the Technical Board of CBBR (Brazilian Commission for Mineral Resources and Reserves), a member of the Executive Board of EMBRAPII’s Unit Tecnogreen, a Research Scholar with FAPESP and CNPq (Brazil) and a member of the Editorial Board of the Mining Technology journal and the Brazil Mineral journal (Please see the link here to Dr. De Tomi’s professional biography: https://bit.ly/3qd93PQ ).
The Company, with the guidance of Dr. De Tomi and the support of NAP.Mineração/USP , has identified two highly prospective areas suitable for the deployment of Newlox Gold’s ESG-focused precious metals processing plants. The projects represent a significant opportunity to the Company and are currently in due diligence.
A Message from Ryan Jackson, President & CEO:
“We are delighted to welcome Professor Giorgio de Tomi to the Newlox team and are looking forward to deploying the Company’s environmentally and socially positive resource development model to Brazil. We are fortunate to have the knowledge and experience of Dr. de Tomi to guide our Brazilian initiative.
The Company has established a close connection with Brazil over many years through its Chief Technical Advisor Dr. Marcello Veiga, who has worked closely with Newlox Gold since 2014 and now heads up the Company’s research and development division . Through our relationship with Dr. Veiga, the Company has been developed a team focused on identifying and assessing expansion opportunities in Latin America, with Brazil at the heart of the endeavour.
We are excited to see Newlox Gold begin its growth program in 2021 and believe that an ambitious expansion in Brazil will be a significant milestone in the Company’s growth strategy. The Brazilian mining industry is several orders of magnitude larger than what is found in Costa Rica, with over 250,000 known artisanal miners operating in the Amazonia region alone.
Dr. De Tomi is currently conducting a World Bank sponsored program in this area to design programs to reduce the social and environmental impact of the artisanal mining sector. Newlox Gold’s partner mining model could play a significant role in the effort.
Newlox Gold has established a beachhead in Brazil through its partnership with Dr. De Tomi and NAP.Mineração/USP. We are eager to initiate the Company’s expansion program beyond Costa Rica and look forward to updating shareholders as we make progress assessing the multiple opportunities available to the Company.”
A Message from Professor Giorgio de Tomi, PhD, CEng, FIMMM:
“It is very encouraging to see Newlox Gold interested in the development of an ASM (artisanal and small scale) mining business in Brazil. Newlox Gold will create partnerships focused on sustainable development that will connect responsible mining with the needs of local communities, generating a framework for economic growth and regional integration.”
- Published in Mining, Newlox Gold, News Home
Affinor Growers Files Patent for Modular Nitrogen Enriched Drying & Curing Vessels
Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI OTCQB: RSSFF) is pleased to announce that it has filed for patent protection for newly designed modular, nitrogen enriched, drying and curing vessels. The Company plans to utilize this mechanical and process design in all its cannabis craft grow operations. The company has plans to grow across Canada and globally.
Affinor will showcase the vessels in its first commercial, greenhouse facility in Abbotsford BC after a cannabis cultivation licence has been received from Health Canada. The planned cannabis production facility will feature a total of 40 growing towers expected to yield 3-4 kg per tower per harvest of dried cannabis every 3 months. The Company also plans to licence a complete turnkey greenhouse with automated vertical growing technology, drying vessels, soil remediation, and all QA protocols required for high quality medical and recreational cannabis production.
Cannabis producers have struggled with drying and curing cannabis at scale. Terpene evaporation, overly dry buds and microbial growth issues have been endemic problems. Affinor’s vessels enable large and small buds to be separated into small batches to deliver exactly what each needs in terms of dry/cure time and environmental conditions. Once terpenes have been locked in, then a nitrogen rich process begins and continues into packaging.
Nick Brusatore CEO: “With this system, buds drying at different rates and plants harvested on different days can be kept separate to avoid having evaporated moisture rehydrate drier batches. It has been known for a long time that the compartmentalization of small batch drying produces higher quality results. The programmed, fine-tuning of multiple dedicated drying vessels is critical for achieving terpene and moisture-content quality. This is a game changer for the cannabis craft grow industry.”
About Affinor
Affinor is a publicly traded company listed on the CSE under the symbol “AFI” and on the OTCQB under the symbol “RSSFF”. Affinor is focused on developing vertical farming technologies and using those technologies to grow fruits, vegetables, and cannabis in a sustainable manner.
To learn more about Affinor, visit: www.affinorgrowers.com
- Published in Affinor Growers, News Home
Canbud’s Subsidiary Empathy Plant Co. Joins the Plant-Based Foods of Canada (PBFC) Association
Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) is pleased to announce that its subsidiary Empathy Plant Co. has joined Plant-Based Foods of Canada (PBFC).
PBFC was founded in 2018 and has since acted as the collective voice of plant-based food companies. As a division of Food, Health & Consumer Products of Canada (FHCP), they work to keep consumers, governments and industry participants informed about the benefits of plant-based foods. The goal of PBFC is to move regulations forward to support innovation, growth and make plant-based eating more available to the masses.
CEO Steve Singh comments: “We applaud the efforts and tireless pursuits of PBFC. With their collective industry voice and amazing expertise, they have been able to help companies like Empathy Plant Co. maneuver more easily in the ever-shifting regulatory landscape in Canada. Their vision and execution are crucial if we are to help move the needle in terms of sustainability. We couldn’t be more thrilled to be part of their mission to make plant-based eating more available to all.”
As Empathy Plant Co. nears commercialization it will benefit from the resources provided by PBFC to help navigate the plant-based CPG (Consumer Packaged Goods) landscape and strengthen their development pipelines. PBFC data-sets and industry insights will help reinforce Empathy Plant Co.’s DTC (Direct to Consumer) and brick and mortar sales strategies. With rapid progressions and pivots in the Canadian health, nutrition and wellness space, alongside PBFC, Empathy Plant Co. will continue to innovate and strive to be part of positive changes in the plant-based environment.
About Canbud Distribution Corporation
Canbud Distribution Corporation is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.
www.canbudcorp.com
https://www.instagram.com/canbudcorp/?hl=en
https://twitter.com/canbudcorp
https://www.linkedin.com/company/canbud-distribution-corp/?viewAsMember=true
https://www.instagram.com/empathyplantco/?hl=en
About PBFC
Plant-Based Foods of Canada (PBFC) acts as a collective voice for the producers of plant-based products. We use our voice to advocate for a modernized regulatory environment that will allow members to market their products effectively and to make them accessible to all consumers.
With this growing demand for plant protein in mind, key members of the plant-based foods industry have come together in PBFC to use our common voice to bring awareness to issues shaping the sector.
Website
https://www.plantbasedfoodscanada.ca/
For further information, please contact:
ir@canbudcorp.com
or
Robert Tjandra, President and COO
Tel: 1 416 847 7312
- Published in Canbud Distribution, News Home